Differentially expressed angiogenic genes in diabetic erectile tissue - results from a microarray screening

Area of Science:

• Endocrinology and Metabolism
• Urology
• Molecular Biology

Background:

• Diabetes mellitus causes metabolic derangements leading to endothelial dysfunction and erectile dysfunction (ED).
• The specific molecular mechanisms of angiogenesis deregulation in the diabetic corpus cavernosum (CC) remain largely uncharacterized.
• Understanding these changes is crucial for developing targeted therapies for diabetic ED.

Purpose of the Study:

• To investigate early and late alterations in cavernosal angiogenic gene expression in diabetes.
• To identify specific molecular pathways affected by diabetes in the corpus cavernosum.
• To evaluate the potential of identified molecules as therapeutic targets for diabetic ED.

Main Methods:

• Utilized streptozotocin-induced diabetic Wistar rats at early (2-week) and established (8-week) disease stages.
• Employed microarray analysis for differential gene expression, validated by quantitative real-time PCR (qrt-PCR).
• Confirmed protein expression and localization using quantitative immunohistochemistry and dual immunofluorescence in both rat and human CC tissues.

Main Results:

• No significant differential gene expression was observed at 2 weeks of diabetes.
• At 8 weeks, 10 angiogenic-related genes were downregulated in diabetic CC, including insulin-like growth factor-1 (Igf1) and natriuretic peptide receptor-1 (Npr1).
• Reduced IGF-1 and NPR-1 protein levels were confirmed in diabetic rat and human CC tissues, with specific cellular localizations identified.

Conclusions:

• Established diabetes leads to significant downregulation of specific angiogenic genes, including IGF-1 and NPR-1, in the corpus cavernosum.
• These molecular changes in angiogenesis are implicated in the pathogenesis of diabetic erectile dysfunction.
• IGF-1 and NPR-1 represent potential preventive and therapeutic targets for managing ED in diabetic patients.